Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Agerafenib hydrochloride

😃Good
Catalog No. T14928Cas No. 1227678-26-3
Alias RXDX-105 hydrochloride, CEP-32496 (hydrochloride)

Agerafenib hydrochloride, a highly potent inhibitor of BRAFV600E (Kd: 14 nM), demonstrates significant efficacy.

Agerafenib hydrochloride

Agerafenib hydrochloride

😃Good
Catalog No. T14928Alias RXDX-105 hydrochloride, CEP-32496 (hydrochloride)Cas No. 1227678-26-3
Agerafenib hydrochloride, a highly potent inhibitor of BRAFV600E (Kd: 14 nM), demonstrates significant efficacy.
Pack SizePriceAvailabilityQuantity
25 mg1.444 €Backorder
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Agerafenib hydrochloride, a highly potent inhibitor of BRAFV600E (Kd: 14 nM), demonstrates significant efficacy.
Targets&IC50
EGFR:22 nM (kd), B-Raf (V600E):14 nM (kd), BRAF:36 nM (kd), c-Kit:2 nM (kd), JAK2:4700 nM (kd), Raf:39 nM (kd), VEGFR2:8 nM (kd), MEK2:8300 nM (kd), MEK1:7100 nM (kd), Abl-1:3 nM (kd), CSF1R:9 nM (kd), EphA2:14 nM (kd), Lck:2 nM (kd), RET:2 nM (kd), c-Met:513 nM (kd)
In vitro
Agerafenib exhibits high potency against several BRAF V600E-dependent cell lines and selective cytotoxicity for tumor cell lines expressing mutant BRAF V600E. It shows potent binding (BRAF V600E, Kd: 14 nM) and cellular activity (pMEK IC50=82 nM and A375 proliferation IC50=78 nM), with activity in the proliferation assay. Agerafenib also exhibits a favorable CYP450 inhibition profile, with measured IC50 values greater than 10 μM versus the CYP1A2, CYP2C9, CYP2D6, and CYP3A4 isoforms and an IC50=3.4 μM versus CYP2C19.
In vivo
Agerafenib exhibits an exceptional PK profile in mouse, dog, and cynomolgus monkey. Administration of Agerafenib to beagle dogs (single dose of 1 mg/kg i.v and 10 mg/kg p.o) results in low clearance (CL=5.0 (mL/min)/kg) and excellent bioavailability (%F=100). Similarly, in cynomolgus monkey, the administration of Agerafenib (single dose of 1 mg/kg i.v and 10 mg/kg p.o) leads to high oral exposure due to low clearance (CL=6.7 mL/min/kg) and excellent bioavailability (%F=100). Oral administration of Agerafenib to Colo-205 tumor xenograft-bearing mice results in significant inhibition of pMEK in tumor cell lysates.
AliasRXDX-105 hydrochloride, CEP-32496 (hydrochloride)
Chemical Properties
Molecular Weight553.92
FormulaC24H23ClF3N5O5
Cas No.1227678-26-3
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Agerafenib hydrochloride | purchase Agerafenib hydrochloride | Agerafenib hydrochloride cost | order Agerafenib hydrochloride | Agerafenib hydrochloride chemical structure | Agerafenib hydrochloride in vivo | Agerafenib hydrochloride in vitro | Agerafenib hydrochloride formula | Agerafenib hydrochloride molecular weight